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Geriatric Division, Internal Medicine Department, Faculty of Medicine, Udayana University, Sanglah Teaching Hospital,  
Denpasar, Indonesia
The elderly population will increase as well as increasing life expectancy. Health problems in elderly will be more complex 
and need a comprehensive management. One of the problems that arise from the aging process is sarcopenia. Sarcopenia is 
a decreasing in muscle mass and muscle strength or muscle function caused by multifactorial not only due to aging process, 
but also nutrition, immobilization, genetics and others risk factors. Muscle is an endogen organ that produces various 
proteins that can affect the health system. This protein is referred to as myokine. Myokine is anti-inflammation cytokine 
and peptide produced by striated muscles. Physical activity results in myokine secretion that can reduce inflammation 
due to a sedentary lifestyle. Inflammation can lead to worsening sarcopenia and fat accumulation in striated muscles, 
thus reducing muscle mass, muscle strength and causing physical inactivity. The most of this type myokine have anti-
inflammation effect have work as autocrine, paracrine and endocrine. Chronic inflammation is a contributor that plays a 
role in the pathophysiology of various diseases including sarcopenia, it will protected by myokine. Myokine can affect the 
metabolism of glucose, fatty acids, angiogenesis, myogenesis, neurogenesis, and can explain the relationship between 
muscle, liver, fat, tissue and brain. Some knewn myokines include interleukin (IL)-6, IL-8, IL-5, brain-derived neurotrophic 
factor (BDNF), fibroblast growth factor 21 (FGF-21), leukemia Inhibitory factor (LIF), irisin and secreted protein acidic and 
rich in cysteine (SPARC). Physical exercise can induce myokine secretion from striated muscle to circulation. Through these 
mechanisms, myokine is expected to improve metabolism of glucose, fat and protein muscle, liver, fat, tissue, brain and 
reduce the incidence some comorbidity especially sarcopenia. Finally, it's will be decreasing of disability, morbidity and 
mortality rate in elderly.
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Introduction
The geriatric population is increasing every year. Based 
on World Health Organization (WHO) data of 2013, in 
1950 there was only 202 million geriatric population, 
increasing 4 fold in 2013 to 841 million inhabitants. This 
increase is dominated in developing countries where the 
geriatric population reaches 554 million in 2013 which 
also increased fivefold from 108 million in 1950. In the 
geriatric population, there is a decrease in the quality and 
quantity of striated muscles called sarcopenia which is 
marked by the loss muscle mass, qualities and functional 
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skeletal muscles progress associated with aging. Sarcopenia 
will cause physical inactivity, and physical inactivity will 
lead to increased proinflammatory markers resulting in 
a vicious cycle of sarcopenia, visceral fat accumulation, 
cardiovascular disease, type II diabetes, malignancy, 
dementia and depression called diseasome of physical 
inactivity.1 Sarcopenia also causes a decrease in muscle 
strength which is one of the causes of frailty that would 
cause a person to become susceptible to stress and increase 
the incidence of hospital admission, disability, or even 
death.2
 Recent developments prove the striated muscle 
produces various cytokines and peptides known as a 
myokine. Some known myokines include interleukin (IL)-
6, IL-8, IL-5, brain-derived neurotrophic factor (BDNF), 
fibroblast growth factor 21 (FGF- 21), leukemia inhibitory 
factor (LIF), irisin and secreted protein acidic and rich in 
cysteine (SPARC).3 Myokine can affect the metabolism 
of glucose and fat, even related to chronic degenerative 
diseases. Understanding of the striated muscles as endocrine 
organs opens our insight into the importance of physical 
activity in disease prevention, especially in the geriatric 
population.
Physiology of Striated Muscles
The striated muscle in our body works voluntarily or 
is influenced by consciousness. The striated muscle is 
composed of myofibrils which combine into muscle fibers. 
The muscle fibers will combine to form the fascism. 
The combination of fascicles will form the muscle. The 
striated muscle cells are cylindrical and have many nuclei. 
Contraction and relaxation begin when the muscles receive 
stimulation from the nervous system. The neuromuscular 
junction is the region between the nerve and the muscle 
in which the neurotransmitter signal is transmitted. The 
muscle fibers are composed of myofibrils having one 
contraction unit called sarcomere. Sarcomere consists of 
two filaments that have thick and thin cross section. Myosin 
thick filaments attached to the M-line located in the middle 
of the sarcomere. Whereas the thin filament actin attaches 
Z-line which is on the edge of the sarcoma. Because actin 
attached to the Z-line at the edge of the sarcomere actin to 
myosin attachment to the process of contraction will cause 
the sarcomere shortens.
 The contraction process is expanded when adenosine 
triphosphate (ATP) in myosin is broken down into adenosine 
diphosphate (ADP) and phosphate, causing myosin to 
become erect and attached to actin. Myosin will remain 
attached to the actin until the new ATP molecule attaches 
to give the muscle time to relax. Actin consists of two 
molecules namely troponin and tropomyosin. When muscles 
relax, tropomyosin blocks actin-attaching sites in myosin. 
When calcium (Ca2+) ions in muscle and ATP are available, 
Ca2+ will stick to troponin and shift tropomyosin. This 
causes no inhibitors between actin and myosin, so actin can 
stick to myosin. Ca2+ is stored in the sarcoplasmic reticulum. 
The acetylcholine neurotransmitter will be released from 
the neuron to the neuromuscular junction causing impulse 
propagation in the T tubule in the muscle and causing the 
release of Ca2+. Ca2+ will stick to the troponin and cause 
contractions that allow us to perform voluntary activities.
 
Myokine
According to WHO, by 2020, chronic diseases will 
constitute 60% of all diseases worldwide. Center for 
Disease Control and Prevention suggests physical inactivity 
is a major cause of chronic diseases, such as diabetes 
mellitus, cardiovascular disease, cancer, dementia and 
depression.  People with physical inactivity have a lifespan 
5 years shorter than those with active physical activity. Type 
2 diabetes mellitus, cardiovascular disease, colon cancer, 
breast cancer, dementia and depression are different diseases 
but have the same pathogenesis of physical inactivity known 
as diseasome of physical inactivity.1 Physical inactivity 
will lead to visceral fat accumulation, insulin resistance, 
atherosclerosis, neurodegeneration and tumors.
 The striated muscle is the largest organ in the human 
body. The last few decades researchers have found a 
connection between striated muscle contractions and 
humoral changes known as muscle-generated exercise 
factor at the time of contracting and affecting metabolism 
in other organs such as liver and adipose tissue. Cytokines 
and peptides produced by striated muscles are known by 
the name myokine. Myokine can work in an autocrine, 
paracrine, or endocrine.4 Myokine gives the concept of how 
muscles interact with other organs. Some known myokines 
include IL-6, IL-8, IL-5, BDNF, FGF-21, LIF, irisin and 
SPARC (Figure 1).
 Physical activity results in myokine secretion that 
can reduce inflammation due to a sedentary lifestyle. 
Inflammation can lead to deterioration of sarcopenia and fat 
accumulation in striated muscles to form a vicious circle that 
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Figure 1. Myokine effect on organs. IL: Interleukin; BDNF: Brain-derived neurotrophic factor; FGF-21: Fibroblast growth factor 21; 
LIF: Leukemia Inhibitory Factor; PGC-1α: proliferator-activated receptor 1 α. 1,10,14-16,20,22,23,26,28
will reduce muscle strength and causes physical inactivity. 
In addition, myokine also works racially through signals in 
the muscles resulting in fat oxidation.4-6 Some myokine that 
has been found to date will be discussed below.
IL-6
IL-6 is the first cytokine introduced as myokine.7 In 2000 
it was found that IL-6 plasma increased with physical 
exercise.8 Afterwards, the study found that the production 
of IL-6 during physical activity increased especially in 
low muscle glycogen conditions.7 IL-6 is produced by 
fiber types I and II in response to muscle contraction.9 In 
striated muscle IL-6 will activate AMP-activated protein 
kinase (AMPK) and or phosphoinositide 3 (PI3) kinase 
which will increase glucose uptake. In addition, IL-6 will 
also increase the translocation of glucose transporter type 
4 (GLUT-4) from intracellular to cell plasma membrane so 
as to increase glucose absorption in striated muscle. This 
suggests an important role of myokine and striated muscle 
in maintaining glucose homeostasis.10
 IL-6 also increases the oxidation of fatty acids in 
striated and whole body cells. It is mediated by AMPK by 
increasing the amount of cAMP and increasing the ratio of 
AMP : ATP.11 In addition, IL-6 in the circulation will increase 
glucose production by the liver during physical activity and 
increase lipolysis. So that the local and systemic effects 
of IL-6 synergistically increase the energy availability for 
muscle contraction.12
 IL-6 was previously thought to be a proinflammatory 
cytokine produced by monocytes and macrophages as a 
response to infection stimulation. However, IL-6 produced 
by striated muscle through contractions does not involve 
other inflammatory mediators such as IL-10 and tumor 
necrosis factor (TNF)-α shows cytokine production because 
physical activity is different from inflammation. The IL-6 
produced by macrophages must pass through the K-β 
nuclear factor pathway to produce B cells (NFKB) while 
the muscle-derived IL-6 is activated through the Ca2+/
nuclear factor of activated T-cell (NFAT) and glycogen /
p38 mitogen activated protein kinase (MAPK). When IL-6 
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is produced by macrophages it produces inflammation, 
whereas IL-6 produced striated lymph cells do not 
activate an inflammatory pathway. Thus IL-6 can be an 
inflammatory and anti-inflammatory cytokine depending 
on the originator.13 During physical activity, IL-6 has an 
anti-inflammatory effect that suppresses the synthesis of 
proinflammatory cytokines such as IL-1β and TNF-α and 
stimulates the production of anti-inflammatory cytokines 
and cytokine inhibitors such as IL-1ra and IL-10.(7) A 
hypothesis that physical activity can increase IL-6 can 
regulate the metabolism of glucose and fat, so it can explain 
the sedentary lifestyle relationship with diseases related to 
glucose and fat metabolism.1
IL-15
IL-15 has anabolic effects that can increase muscle growth. 
IL-15 can stimulate the differentiation of myocytes and 
increase the amount of protein in myocytes.14 In addition, 
IL-15 is also thought to affect fat metabolism. There was 
an inverse correlation between plasma levels of IL-15 and 
body fat mass and elevated IL-15 levels showed a decrease 
in visceral fat in experimental mice.15
BDNF
BDNF is a neurotrophin, which is structurally similar to a 
growth factor that affects survival, neuronal growth so as 
to relate to learning and memory. BDNF works through the 
Trk receptor on tyrosine kinase. BDNF is mostly produced 
by the brain and non-neurogenic tissues including striated 
muscles. Alzheimer's patients have low plasma BDNF 
levels. In addition, low levels of BDNF are also found in 
patients  with  acute  coronary  syndrome  and diabetes 
mellitus. Unlike other circulating myokines circulating, 
BDNF works directly on striated muscles by increasing the 
oxidation of fat through the AMPK pathway thus increasing 
adipose fat tissue.16 From this, it can be concluded that 
physical activity will increase fat metabolism, decreased 
visceral fat, decreased cardiovascular risk, diabetes mellitus, 
dementia through BDNF production.17
IL-8
IL-8 is a chemokine to attract neutrophils. IL-8 increases 
in physical activity such as running that involve the 
contraction of eccentric muscles.18 The measurements of 
IL-8 arterial and venous concentrations showed an increase 
while IL-8 concentrations did not increase the systemic 
concentration of IL-8. This indicates that IL-8 works in 
an autocrine and paracrine.19 In addition, the increase in 
IL-8 in eccentric muscle cells did not show an increase 
in neutrophils and macrophages in muscle cells. The IL-8 
angiogenesis effect was obtained through the activation 
of C-X-C chemokine receptor type 2 (CXCR2) receptor. 
The CXCR2 receptor increases in striated muscle biopsy 
after eccentric contraction. IL-8 induces angiogenesis and 
increases proliferation in endothelial cells.20
FGF-21
FGF-21 is known as the hormone produced by the liver 
during fasting. This hormone induces the liver to produce 
peroxisome proliferator-activated receptor 1 α (PGC-1α) 
that regulates energy homeostasis, increases fatty acid 
oxidation, and gluconeogenesis. PGC-1α-deficient rats 
have impaired  gluconeogenesis  and  ketogenesis.21 In 
experiments with infusion of insulin in healthy men, FGF-
21 was almost undetectable in patients prior to insulin 
infusion. However, after 3-4 hours there was an increase in 
FGF21 produced by striated muscle followed by an increase 
in plasma FGF-21 thus indicating FGF-21 is a myokine that 
serves to regulate insulin.22
LIF
LIF is a newly discovered myokine and plays an important 
role in muscle hypertrophy as it increases cell proliferation 
via the Janus kinase (JAK) pathway, transducer and activator 
of transcription-3 (STAT-3) signals, and phosphoinositide-3-
kinase. LIF affects cell proliferation so it plays an important 
role in hypertrophy and cell regeneration.23 LIF mRNA was 
found to increase after an ergometer cycle and endurance 
exercise.24,25 LIF has the potential to treat diseases of striated 
muscles such as muscular dystrophy because it increases 
myoblast survival in dystrophic muscle.24 However, further 
research is needed to find out the duet increase in LIF 
mRNA, the type of exercise suggested, and the time it takes 
to improve LIF.
Irisin
Irisin is a myokine whose production depends on the 
peroxisome proliferator-activated receptor-γ coactivator-1 
α (PPAR-γ) coactivator-1α (PGC1-α), where PGC1- α will 
stimulate the expression of fibronectin gene type III domain-
containing protein 5 (FNDC5) which encodes irisin. Irisin 
works on adipose tissue by inducing the conversion of 
white fat to brown fat. This increases the increase in energy 
requirements thus improving glucose homeostasis. In 
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addition, FNDC5 is also expressed in the brain. Increased 
irisin will increase FNDC5 in the brain which will increase 
BDNF resulting in neurogenesis in the brain. The FNDC5/
irisin pathway is a pathway that explains the relationship 
between physical exercise and the brain.26 In addition, irisin 
also regulates muscle metabolism. Muscles given in vitro 
irisin will increase the expression of PGC-1α, mitochondrial 
transcription factor A (TFAM), GLUT4 and will strengthen 
the signal between PGC-1α and FNDC5 resulting in 
increased energy demand and metabolism in the muscle.
SPARC
The SPARC, also known as B40, was first discovered on the 
bone and was named osteonectin. But recent studies have 
also found that SPARC is found in myoblasts, myotubes, 
and muscle fibers. SPARC is one of myokine that plays a 
role in fat accumulation and glucose metabolism. SPARC 
modulates fibronectin which is the inhibitor of extracellular 
matrix production during adipogenesis. This interruption of 
extracellular matrix production results in fiber regulatory 
constraints for preadipocyte cell structures.27 SPARC also 
plays a role in regulating blood sugar through AMPK 
signals that can stimulate glucose uptake by cells through 
enhancement of GLUT translocation.28
The Release of Myokine by Contracting 
Muscles
The role of cytokines in the pathophysiology of the disease 
is growing rapidly. It has been known for a long time that the 
concentration of IL-6 increases during physical activity but 
the origin of this increase is only known since 2000. IL-6 is 
produced by skeletal muscle and is released into circulation 
so that IL-6 is one of the cytokines released by striated 
muscle, which known as myokine.29 The concentration of 
IL-6 in plasma increases up to 100-fold during physical 
exercise. This increase is also accompanied by an increase 
in the inhibitor of the antagonist interleukine-1 receptor 
cytokine (IL-1ra) and anti-inflammatory cytokines such 
as IL-10. Initially, estimated IL-6 increase after physical 
activity is caused by an immunological response caused by 
local damage from striated muscle after physical exercise 
and immune cells. However, the results of the cytometric 
examination showed a decrease in the number, percentage, 
and mean of monocyte intensity which gave positive 
replication to IL-6 after physical exercise, so it can be 
concluded that IL-6 increased after physical activity did not 
involve the immune system.12
 The striated muscle in humans is a unique organ that 
can produce IL-6 during contractions without an increase 
in inflammatory markers. The expression of IL-6 mRNA is 
affected by muscle glycogen levels where there is an increase 
in IL-6 mRNA levels in muscles with low glycogen. There 
are several hypotheses about the way in which IL-6 gene 
transcription is stimulated. At a time when the carbohydrates 
in the muscles decrease, a sympathoadrenal response occurs 
which results in epinephrine expulsion that stimulates the 
transcription of IL-6 gene through β-adrenergic stimulation 
of protein kinase A. However, after experiments using rats 
it is found that the increase in m-RNA IL-6 occurs only on 
administration of epinephrine a dose of 1000 nmol, but not 
on physiological dosage (10 and 100 nmol). In addition, 
transcription of the IL-6 gene is also estimated through 
the release of calcium (Ca2+) in the lateral pouch of the 
endoplasmic reticulum. The striated muscle gave calcium 
ionophore ionomycin 5 nmol will increase the expression of 
IL-6 mRNA.30
 In the contraction experiment, we measured the 
difference between IL-6 artery and vein on contracting and 
non-contraction muscles. The difference in contraction of 
IL-6 was found to be significantly greater.8 In addition, 
other studies have also shown that there is an increased 
concentration of IL-6 in the biopsy of ribonucleic acid 
(mRNA)  muscle  contractors.12  It  can  therefore  be 
concluded that the transcription of IL-6 gene during 
contraction is determined by the levels of calcium and 
glycogen levels.
 To investigate intracellular signals that play a role in 
transcription of IL-6 gene, experiments were conducted 
in two circumstances with normal and low carbohydrate 
diets and biopsies were performed to determine levels of 
IL-6 mRNA and nuclear proteins such as c-Jun N-terminal 
kinases (JNK) and MAPK. There was an increase in IL-6 
in the contracting muscle. There was also an increase in 
phosphorylation of p38 in muscles previously given a low-
carbohydrate diet.31
Sarcopenia
Sarcopenia is the term first introduced by Irwin Rosenberg 
in 1989. Sarcopenia comes from the Greek word "Sarco" 
which means meat or muscle and "penia" which means 
deficiency. Sarcopenia is defined as a lack of muscle mass. 
Currently, the term is aimed at a loss of muscle mass and 
strength with age.32 Loss of muscle mass was first observed 
by an English neurologist named MacDonald Critchley who 
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discovered the loss of muscle mass in the hands and feet of 
geriatric patients. Currently, sarcopenia is defined as loss of 
muscle mass in the elderly below 2 standard deviations of 
the average young adult muscle mass.33
 Based on the epidemiological data the prevalence of 
sarcopenia is 30% at the age of more than 60 years, and 50% 
at the age of more than 80 years.33 It is estimated there are 
3.6 million people in the United States who have sarcopenia. 
Sarcopenia is a complex medical condition characterized by 
progressive loss of muscle mass, the quality and function 
of skeletal muscles associated with aging. Sarcopenia 
also causes a decrease in muscle strength. A decrease in 
muscle strength is one of the causes of frailty. Frailty can 
cause a person to be vulnerable to stress were experiencing 
a little stress will cause their condition to deteriorate like 
hospitalization, disability, or even death.2 Symptoms of 
frailty are a weakness, inability to climb one ladder, inability 
to walk a block, have more than five diseases, and weight 
loss.33
 There are various risk factors for the occurrence of 
sarcopenia that can be divided into some factors.
Constitutional factors
Age and sex affect sarcopenia. Low birth weight increases 
the risk of sarcopenia.
Aging factor
Aging causes increased catabolic stimulation and decrease 
anabolic stimulation. Hormonal dysregulation such as 
testosterone, growth hormone and insulin like growth 
factor (IGF)-1 also occur during aging. Muscle contractions 
resulting from physical exercise will lead to the release of 
growth factors such as IGF-Ea and cause protein synthesis 
and muscle regeneration. In aging physical inactivity often 
occurs so that the release of IGF becomes reduced and leads 
to decreased muscle synthesis. Testosterone also plays a 
role in decreasing muscle mass and strength. Testosterone 
decreases by 1% after the age of 30 years in men while 
starting to decline at the age of 25 to 40 years in women.34 
Several studies have shown that low doses of testosterone 
can increase muscle mass.35 While in other studies showed 
the provision of testosterone in frailty patients associated 
with decreased mortality compared with placebo.36 In 
adults, growth hormone increases nitrogen retention and 
muscle mass. Vitamin D 25 (OH) will decrease with aging. 
Vitamin D 25 (OH) levels in old age will cause sarcopenia, 
fall, hip fracture and death.36
Lifestyle
Decreased intake of foods, especially protein with physical 
activity that less increases the risk of sarcopenia. Nutrition is 
needed to maintain muscle mass. Geriatric patients require 
1.2 grams of protein/kilogram of body weight per day. 
Amino leucine acids can increase protein synthesis better 
than other amino acids. Leucine-containing foods include 
milk,  cheese,  beef,  tuna,  chicken,  beans, soybeans  and 
eggs.37 Consumption of alcohol and cigarettes also increases 
the risk of sarcopenia.
Changes in body condition 
Late bed rest, immobilization, and less weight increase the 
risk of sarcopenia.
Chronic illness
Chronic diseases such as diabetes, advanced functional 
organ failure, cognitive disorders and mood disorders cause 
chronic inflammation that can lead to sarcopenia.
Sarcopenia and Aging
Sarcopenia occurs due to the multifactorial process of 
losing alpha motor nerve inputs to the spinal columns, 
physical activity, hormonal changes, energy, protein intake, 
oxidative stress and inflammatory processes.38 Sarcopenia 
due to aging is explained by the immunosenescence that is 
the decrease of the immune system, resulting in low-grade 
inflammatory conditions in the long term is often called 
chronic inflammation aging conditions (Figure 2). This 
inflammatory process is based on CD68+ and macrophage 
infiltration resulting in anabolic and catabolic protein 
imbalance. In the aging process occurs mitochondrial 
dysfunction as an energy producer, redox regulation, and 
communication with cell nuclei, gene expression, and 
Figure 2. The relationship of aging with sarcopenia.39
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apoptotic processes. So mitochondria function to maintain 
their functional integrity and structure during the process 
of biogenesis, antioxidants, fusion and fission dynamics, 
and autophagy. PGC-1α functions to control transcriptional 
regulation of some nuclei and mitochondrial genes. So PGC-
1α can play a role in controlling the function and muscle 
mass. Activation PGC-1α protects muscle from degradation 
and destruction by proteolysis, oxidative, inflammation and 
aproposis. Physical exercise is a very powerful stimulation 
stimulating PGC-1α expression.39
 Chronic inflammation that produces many 
proinflammatory cytokines will activate signal catabolism 
and upregulation of inflammatory pathways such as NF-ƘB 
and STAT3 thereby increasing the activation of ubiquitin-
proteasome and autophagy systems. This process not only 
increases proinflammatory cytokines but also inhibits the 
secretion of anti-inflammatory cytokines such as IL-10. 
Cytokines are produced by various inflammatory cells 
and stoma cells as well as skeletal muscle cells. In mature 
myofiber muscle cells will form muscle mass while myotine 
will express m RNA of various cytokines.39 Several factors 
can reduce and even prevent inflammation that causes 
sarcoopenia, such as exercise, nutritional intake, hormonal 
therapy and pharmacotherapy.
 Enforcement of sarcopenia diagnosis is based on 
various risk factors reinforced by muscle weakness, 
fatigue, low endurance associated with a decreased speed 
of walking, movement disorders and inability to perform 
daily tasks. Enforcement of sarcopenia diagnosis is based 
on various risk factors reinforced by muscle weakness, 
fatigue, low endurance associated with a decreased speed of 
walking, movement disorders and inability to perform daily 
tasks. Based on the European Working Group on Sarcopenia 
in Older People (EWGSOP), a criterion for sarcopenia is the 
loss of muscle mass coupled with one of two conditions: loss 
of muscle strength and or loss of performance.40,41 Physical 
performance can be measured with gait speed, up stair test 
and time up and go test. If one of the tests gives a positive 
result of walking speed <0.8 meters/second and can not 
stand from the chair then the muscle mass measurements 
are taken. Examination of muscle mass using bioelectrical 
impedance (BIA) by measuring the ratio between muscle 
mass and fat mass. If still found the results are dubious then 
conducted a dual energy inspection X-ray absorptiometry 
(DEXA). While the gold standard to determine the ratio of 
muscle mass and fat mass is through computed tomography 
(CT) scanning or magnetic resonance imaging (MRI). 
The Role of Physical Exercise in Myokine 
Enhancement
Physical exercise can induce myokine secretion from 
striated muscle to circulation. In conditions of metabolic 
climates such as diabetes mellitus and obesity, adipose 
tissue will amplify proinflammatory cytokines that cause 
pathological processes such as atherosclerosis and insulin 
resistance. In addition, myokine expenditure can inhibit 
the effects of adipokines. In response to exercise, striated 
muscles release myokines such as irisin, IL-15, LIF, BDNF, 
FGF-21 and SPARC that have local effects on muscles or to 
target organs.
 Table 1 shows the studies that is showing the 
relationship between physical exercise and increased serum 
myokine.
The Role of Physical Exercise in Chronic 
Inflammation in Geriatric Patients
Chronic inflammation of geriatric populations causes a 
loss of muscle mass resulting in disability and even death. 
The levels of pro-inflammatory cytokines in the geriatric 
population were higher than in the young adult population. 
Figure 3. Clinical approach of sarcopenia diagnosis. BIA: 
bioelectrical impedance (BIA); DEXA: dual energy X-ray 
absorptiometry.42
Muscle strength can be measured by 2 way tests, which 
are grasping strength tests and knee extension tests. The 
criterion for decreasing muscle strength according to 
AWGS is less than 20 percentile of the average population 
of grasping strength tests (Figure 3).42
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Myokine Physical training Results
IL-6 Exercise knee extensor contraction (concentric) for 5 hours ↑ IL-6 (8)
IL-15 Treadmill ↑ serum IL-15 (44)
(70% maximum heart rate, 30 minutes)
Resistance training ↑ IL-6, IL-10, IL-1ra, IL-8 (45)
(4 sets, 10 repetitions, 2-3 minutes break every interval)
Resistance training ↑ serum IL- 15 (46)
(3 days per week, 6-10 repetitions)
BDNF Cycling ↑ BDNF MRNA, 
(VO2 maximum of 60%, 120 minutes) ↑ protein BDNF (16)
LIF Resistance training ↑ LIF MRNA up to 9 times (24)
Cycle ergometer ↑ LIF MRNA up to 4.5 times (25)
(3 hours, VO2 maximum 60%)
Irisin Endurance exercise ↑ plasma irisin
(cycling, maximum VO2 65%, 4-5 sessions)
Acute exercise ↑ plasma irisin (47)
FGF-21 Treadmill ↑ FGF-21 (48)
 (Bruce’s protocol 5 days/2 weeks, 21 minutes)
SPARC Acute exercise ↑ SPARC (49)
(cycling, VO2 maximum 70%, 30 minutes)
Table 1. Research on physical exercise that induces myokine.43
BDNF: brain-derived neurotropic factor; FGF-21: fibroblast growth factor 21; IL: interleukin; LIF: leukemia 
inhibitory factor; SPARC: secreted protein acidic and rich in cysteine.
Some cytokines have a poor direct effect on striated muscle 
causing loss of muscle fibers, so the inflammatory pathway 
is a target of intervention that can decrease the incidence 
of disability in the geriatric population. The use of anti-
inflammatory can indeed reduce inflammation that occurs in 
geriatric patients, but the side effects caused a limitation of 
the use of an anti-inflammatory. To date, no pharmacological 
drugs with anti-inflammatory effects have been used to 
treat sarcopenia in geriatric populations. Regular physical 
exercise is the only therapy to improve physical function in 
the geriatric population.
 Large observational studies such as the British Regional 
Heart Study, the Third National Health and Nutrition 
Examination Survey (NHANESIII), and the Cardiovascular 
Health Study (CHS), show an inverse relationship between 
CRP concentration and physical activity in the elderly. In 
the ABC Health study also found a linear decrease in TNF 
tendency with increased physical activity.5 In NHANESIII 
study, physical activity of more than 22 times per month 
decreased CRP by 63% compared with physical activity 
less than 3 times per month without being affected by BMI 
and waist to hip ratio.1 Other studies also showed aerobic 
exercise decreased the production of atherogenic cytokines 
by mononuclear cells such as interferon γ, TNF α and IL-1 
and increased production of atheroprotective cytokines such 
as IL-10, IL-4 and transforming growth factor (TGF)-b1 
increased by 36%.28 The cause of this is increased myokine 
during physical exercise. As mentioned before, the striated 
muscle that expresses myokine, especially IL-6 which 
will cause metabolic changes during physical activity. The 
release of IL-6 to more than 100-fold during contractions in 
addition to enhancing anti-inflammatory cytokines such as 
IL-1ra and IL-10 may also decrease the production of TNF 
α and IL-1β.16
Conclusion
Chronic inflammation is a contributor that plays a role in the 
pathophysiology of various diseases including sarcopenia. 
Provision of therapy to reduce inflammation is crucial, but 
the pharmacological approach has not shown significant 
results. Various studies have shown that physical activity 
can stimulate myokine secretion from contracted striated 
muscles. Some known myokines include IL-6, IL-8, IL-
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5, BDNF, FGF-21, LIF, irisin and SPARC. Myokine can 
affect the metabolism of glucose, fatty acids, angiogenesis, 
neurogenesis and can explain the relationship between 
striated muscles with the liver, fat tissue and brain. Through 
this mechanism, physical activity is expected to reduce 
the incidence of sarcopenia and diseasome of physical 
inactivity, especially in geriatric populations.
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